BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37352188)

  • 1. Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol.
    Sahay S; Bangar S; Chandhiok N
    PLoS One; 2023; 18(6):e0287454. PubMed ID: 37352188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
    Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
    Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
    Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.
    Sullivan PS; Phaswana-Mafuya N; Baral SD; Valencia R; Zahn R; Dominguez K; Yah CS; Jones J; Kgatitswe LB; McNaghten AD; Siegler AJ; Sanchez TH; Bekker LG
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
    Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
    PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demand creation and retention strategies for oral pre-exposure prophylaxis for HIV prevention among men who have sex with men and transgender women: a systematic review and meta-analysis.
    Guimarães NS; Magno L; Monteiro GMB; Ramos ICN; de Castro CT; Aranha-Rossi TR; Pereira M; Dourado I
    BMC Infect Dis; 2023 Nov; 23(1):793. PubMed ID: 37964202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil.
    Echeverría-Guevara A; Coelho LE; Veloso VG; Pimenta MC; Hoagland B; Moreira RI; Leite I; Jalil EM; Cardoso SW; Torres TS; Grinsztejn B
    Braz J Infect Dis; 2023; 27(1):102733. PubMed ID: 36586721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PrEP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya.
    Kimani M; van der Elst EM; Chiro O; Oduor C; Wahome E; Kazungu W; Shally M; Rinke de Wit TF; Graham SM; Operario D; Sanders EJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25323. PubMed ID: 31194291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.
    Psaros C; Goodman GR; Lee JS; Rice W; Kelley CF; Oyedele T; Coelho LE; Phanuphak N; Singh Y; Middelkoop K; Griffith S; McCauley M; Rooney J; Rinehart AR; Clark J; Go V; Sugarman J; Fields SD; Adeyeye A; Grinsztejn B; Landovitz RJ; Safren SA;
    J Int AIDS Soc; 2024 May; 27(5):e26252. PubMed ID: 38783534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges.
    Veloso VG; Mesquita F; Grinsztejn B
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20010. PubMed ID: 26198347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Prevention Services for Hispanic/Latino Persons in THRIVE, 2015-2020.
    Bonacci RA; Tanner MR; Zhu W; Hayes T; Dominguez KL; Iqbal K; Wiener J; Drezner K; Jennings JM; Tsoi B; Wendell D; Hoover KW;
    Am J Prev Med; 2023 Aug; 65(2):213-220. PubMed ID: 36872151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
    Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
    Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary Recruitment Strategies to Reach Men Who Have Sex with Men and Transgender Women: The Experience of a Large Brazilian HIV Prevention Service.
    Bezerra DRB; Jalil CM; Jalil EM; Coelho LE; Carvalheira E; Freitas J; Monteiro L; Santos T; Souza C; Hoagland B; Veloso VG; Grinsztejn B; Cardoso SW; Torres TS
    AIDS Behav; 2022 Aug; 26(8):2643-2652. PubMed ID: 35122578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.